Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for
about
PARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase III study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerMaintenance therapy in NSCLC: why? To whom? Which agent?Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patientsPersonalized medicine for lung cancer: new challenges for pathology.Thymidylate Synthase as a Predictive Biomarker for Pemetrexed Response in NSCLC.Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways.Post-study therapy as a source of confounding in survival analysis of first-line studies in patients with advanced non-small-cell lung cancerUse of pemetrexed for non-small cell lung cancer in the Andalusian public health system.Maintenance Chemotherapy Use for Advanced Non-Small Cell Lung Cancer in an Australian Cancer Centre.Severe immune hemolytic anemia due to pemetrexed in a patient with non-small cell lung cancer.
P2860
Q34041708-8262E82F-DE80-4F80-A78B-1790860046FAQ35041521-AB2048A5-711F-44B6-93CA-D2C19249AE74Q37152528-DB1752DF-0700-4417-A46A-9F33F3A25BB9Q37932029-28CF75FA-AF45-4948-966A-95A4B83B6A44Q38575758-1BE48004-5432-4980-8402-1AD8CFE4566BQ39014579-D7AB706D-43CD-4197-9249-21DC0D6C4CEAQ40342327-F101C737-B27A-4FBB-AACD-650A2F166680Q41740552-9A4AFB7C-7A9B-4DDD-BB07-A876F94FDF27Q47136657-AE7600C2-AD3C-4F41-AE30-02EA800AAD71Q50524728-269ADAF8-39DE-4A4C-B891-BAFABEA35DA6
P2860
Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment rationale and study ...... pemetrexed plus cisplatin for
@nl
type
label
Treatment rationale and study ...... pemetrexed plus cisplatin for
@nl
prefLabel
Treatment rationale and study ...... pemetrexed plus cisplatin for
@nl
P2093
P2860
P3181
P356
P1433
P1476
Treatment rationale and study ...... ous non-small cell lung cancer
@en
P2093
Alexandra Thareau Vaury
Carla Visseren-Grul
Francesca Russo
Jesús Corral Jaime
Luis G Paz-Ares
Sedat Altug
P2860
P2888
P3181
P356
10.1186/1471-2407-10-85
P407
P577
2010-01-01T00:00:00Z
P5875
P6179
1042610873